Episode 4
1hr 00 mins
Strap in for a groundbreaking episode of the RealPharma Podcast with Dr. Khalil Ramadi, where we'll navigate the cutting-edge world of bioengineering, exploring how it's revolutionizing healthcare and the way we think about medicine's future.
Summary
Dr. Khalil Ramadi, an assistant professor at New York University Abu Dhabi, discusses the field of bioengineering and his work in neuromodulation and ingestible electronics. He explains that bioengineering encompasses tinkering with biology and physiology, and its focus has shifted from building hardware tools for the clinic to devices that can be implanted in the body. Dr. Ramadi's interest in neuromodulation stems from the need to improve brain technologies and find non-invasive ways to target specific areas of the body. He also explores the potential applications of neuromodulation in areas such as obesity, eating disorders, and diabetes. The challenges in bioengineering include regulatory issues, access to innovations, and the scalability of devices. In this conversation, Khalil Ramadi discusses the field of bioengineering and its potential impact on healthcare. He shares insights on the future of bioengineering education, emphasizing the need for innovation and commercialization. Khalil also predicts advancements in personalized care and the potential for new technologies to diagnose and treat diseases. He highlights the importance of finding inspiration and overcoming challenges in the field. Lastly, he introduces Project Prana Foundation, a nonprofit organization focused on developing technologies for decentralized care.
Takeaways
Bioengineering involves tinkering with biology and physiology to develop innovative medical devices and technologies.
Neuromodulation is a field within bioengineering that focuses on targeting specific areas of the body using electrical stimulation.
Ingestible electronics, such as the FLASH pill, have the potential to stimulate appetite and promote eating in patients with conditions like chemotherapy-induced nausea or eating disorders.
The future of bioengineering and pharma may involve the convergence of the two fields, with pharma companies incorporating bioengineering technologies into their offerings.
Ensuring access to bioengineering innovations is a challenge that requires addressing logistical, financial, and regulatory barriers. Bioengineering education should focus on innovation and commercialization to bridge the gap between research and tangible products.
Advancements in personalized care and diagnostic technologies will revolutionize healthcare.
Finding inspiration and overcoming challenges are crucial for success in bioengineering.
Project Prana Foundation is a nonprofit organization working on technologies for decentralized care.
Chapters
00:00 Introduction to Dr. Khalil Ramadi
03:47 Defining Bioengineering
06:33 Dr. Ramadi's Journey into Bioengineering
10:30 The Role of a Bioengineer
11:56 Focus on Neuromodulation and Ingestible Electronics
16:41 The Gut-Brain Connection
17:26 Applications of Neuromodulation
20:38 Neuralink and the Future of Bioengineering
25:05 Neuromodulation and GLP-1 Agonists
29:27 Challenges in Bioengineering
33:33 The Future of Pharma and Bioengineering
36:18 Ensuring Access to Bioengineering Innovations
40:20 The FLASH Pill and Appetite Stimulation
47:02 The Future of Bioengineering Education
51:10 Predictions for the Next 10 Years
55:00 Finding Inspiration and Overcoming Challenges
58:31 Project Prana Foundation
Resources:
Dr. Khalil Ramadi
Ramadi Lab
Ingestible electronics: Science Robotics paper for gastric stimulation: https://www.science.org/doi/10.1126/scirobotics.ade9676
Project Prana
Nano Robots Shrink Bladder Cancer
Light Powered Yeast
DNA Detection Advances